As of April 30, 2025, there are 82 publicly listed companies in China engaged in the in vitro diagnostics (IVD) industry. Among them, 61 companies focus primarily on IVD, while 21 have IVD as part of their broader business portfolios.

In 2024, China’s IVD market size is expected to be less than RMB 120 billion, remaining flat compared to 2023. Domestic brands account for approximately 50% of the market.

On June 23, 2021, Suzhou Nanomicro Technology Co., Ltd. was listed on SSE STAR Market. Stock code: 688690. The number of A shares publicly issued this time is 44 million shares, the issue price is 8.07 yuan/share, and the opening price is 93.00 yuan/share.

On the evening of June 21st, Sansure acquired a 14.77% equity interest in GeneMind through equity transfer and subscription of newly added registered capital at a cost of RMB 255.2 million. When the transaction is completed, Sansure will become the second largest shareholder of GeneMind.

JP Morgan and Cowen said on Monday they have initiated coverage of shares of Singular Genomics Systems.JP Morgan gave the shares an Overweight rating and a price target of $30 while Cowen gave them an Outperform rating.

Roche announced recently that its RT-PCR-based Cobas SARS-CoV-2 nucleic acid test for use on the Cobas Liat system has received Emergency Use Authorization from the US Food and Drug Administration.

A new antibody testing study examining samples originally collected through the National Institutes of Health’s All of Us Research Program found evidence of SARS-CoV-2 infections in five states earlier than had initially been reported.

WASHINGTON, June 17, 2021 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") announced today that Danaher has entered into a definitive agreement to acquire privately held Aldevron, for a cash purchase price of approximately $9.6 billion.

Exponent announces that it has reached an agreement to sell BBI Group (“BBI”), a leading supplier of products and services to the global diagnostics and life sciences industries, to Novo Holdings A/S, a leading global life sciences investor, for an enterprise value of over ￡400 million.

On June 16, 2021, AVE Science & Technology Co. Ltd. was listed on the Sci-Tech innovation board. The number of A shares publicly issued this time is 17 million shares, the issue price is 14.71 yuan/share, the opening price is 38.24 yuan/share, and the maximum increase at the time of press is 207%.

On June 13, local time, G7 summit closed in Cornwall, England. According to the Global Times previously reported, Euro news reporter Jack Parrock (Jack Parrock) posted a picture on social media and found that the lateral flow COVID tests we have to do every day at G7 summit are “made in China”.

The landscape of the medical device industry is changing.